SKYI Stock Overview
Engages in selling cannabidiol products using pharmaceutical grade ingredients. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Sky Century Investment, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0011 |
| 52 Week High | US$0.0054 |
| 52 Week Low | US$0.0011 |
| Beta | 3.05 |
| 11 Month Change | -67.65% |
| 3 Month Change | n/a |
| 1 Year Change | -75.00% |
| 33 Year Change | -98.43% |
| 5 Year Change | n/a |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| SKYI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -67.6% | 2.0% | 1.6% |
| 1Y | -75.0% | 7.5% | 32.3% |
Return vs Industry: SKYI underperformed the US Healthcare industry which returned 4.6% over the past year.
Return vs Market: SKYI underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| SKYI volatility | |
|---|---|
| SKYI Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SKYI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine SKYI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1 | Nataliia Petranetska | skygcbd.com |
Sky Century Investment, Inc. engages in selling cannabidiol products using pharmaceutical grade ingredients. It also provides a range of online services that includes digital marketing, SEO, analytics, reporting, content and website design, and mail marketing services for CBD companies. In addition, the company operates cannabis news application that offers cannabis related news from various sources.
Sky Century Investment, Inc. Fundamentals Summary
| SKYI fundamental statistics | |
|---|---|
| Market cap | US$750.17k |
| Earnings (TTM) | -US$136.62k |
| Revenue (TTM) | US$74.76k |
3.2x
P/S Ratio-1.8x
P/E RatioIs SKYI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKYI income statement (TTM) | |
|---|---|
| Revenue | US$74.76k |
| Cost of Revenue | US$0 |
| Gross Profit | US$74.76k |
| Other Expenses | US$211.38k |
| Earnings | -US$136.62k |
Last Reported Earnings
May 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00062 |
| Gross Margin | 100.00% |
| Net Profit Margin | -182.74% |
| Debt/Equity Ratio | -46.0% |
How did SKYI perform over the long term?
See historical performance and comparison